PHVS

Conviction 100HealthcareScan · Thu, Jun 25, 2026

Shooting star

PHVS$33.30+0.03%

ResistanceSupportVol 14Insider sell

Vol MA14 416.09K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Pharvaris N.V.Biotechnologywww.pharvaris.com ↗

Price33.30

Change+0.03%

Gap+1.74%

Rel volume4.40×

Avg volume402.65K

Avg $ vol12.78M

SMA 2031.53

SMA 5030.41

SMA 20026.65

Price vs 50+9.52%

Price vs 200+24.95%

MA stackbullish

50/200 cross—

Supertrendup · 29.44

RSI (14)62

MACD hist0.16

MACD cross—

Stoch %K / %D61 / 72

ADX (14)30

+DI / −DI28 / 8

RSI divergence—

MACD divergence—

ATR %+4.77%

ADR %4.81%

52w high33.41

52w low17.00

From 52w high-0.33%

Above 52w low+95.88%

New 52w highYes

SqueezeOff

Bollinger width17.17%

%B0.83

Donchian pos71.12%

Donchian high35.27

Donchian low28.46

AVWAP (52w high)33.95

vs AVWAP high-1.92%

AVWAP (52w low)26.62

vs AVWAP low+25.08%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d4.40×

Avg vol (14d)416.09K

Avg vol (20d)402.65K

Avg $ vol (20d)12.78M

Market cap2.17B

RS 3m (vs SPY)+19.12%

RS 6m (vs SPY)+22.35%

RS line new highYes

Trend template8/8

Technical rank86.2

1 week-0.33%

1 month+11.45%

3 months+27.34%

6 months+23.01%

1 year+93.60%

YTD+25.76%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target49.60

Target upside48.95%

Analyst ratingBuy

Institutional85.12%

Ent. value2.17B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees129

ListedFri, Feb 5, 2021

Free float40.17M

Float %57.5%

Short interest708.63K

Days to cover2.6d

Short volume26.2%

Squeeze score32 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.70 vs −$0.76

Last surprise+7.9% beat

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank86.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Congress activity

Disclosed STOCK Act trades in PHVS

All disclosures →

No recent disclosed trades by Congress in PHVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHVS · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Nijdam Anna Principal Accounting Officer · Common Stock · 2026-06-04	Sell	2.67K	$82K	2026-06-04	2026-06-08
Nijdam Anna Principal Accounting Officer · Common Stock · 2026-05-22	Sell	5.5K	$169K	2026-05-22	2026-05-26
Nijdam Anna Principal Accounting Officer · Common Stock · 2026-05-22	Exercise	5.5K	$110K	2026-05-22	2026-05-26
Nijdam Anna Principal Accounting Officer · Stock Option (Right to Buy) · 2026-05-22	Exercise	5.5K	$0	2026-05-22	2026-05-26
Nassif David W. CFO / CLO · Common Stock · 2026-05-21	Sell	10K	$303K	2026-05-21	2026-05-26
Nijdam Anna Principal Accounting Officer · Stock Option (Right to Buy) · 2026-05-21	Exercise	1.83K	$0	2026-05-21	2026-05-26
Nijdam Anna Principal Accounting Officer · Common Stock · 2026-05-21	Exercise	1.83K	$37K	2026-05-21	2026-05-26
Monges Viviane Director · Common Stock · 2026-05-21	Sell	9.67K	$293K	2026-05-21	2026-05-26
Nijdam Anna Principal Accounting Officer · Common Stock · 2026-05-21	Sell	1.83K	$56K	2026-05-21	2026-05-26
Bjork Elisabeth Director · Common Stock · 2026-05-20	Sell	10K	$293K	2026-05-20	2026-05-22

SEC filings

EDGAR filings in PHVS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.